Cardax Initiates Monkey Study to Compare Bioavailability of Patented Consumer Health Product Candidate CDX-085 to Microalgal Astaxanthin

Business News
Print
HONOLULU--(BUSINESS WIRE)--Cardax initiated a monkey study to compare the bioavailability of CDX-085, its patented product candidate, to microalgal astaxanthin, the predominate astaxanthin consumer health form on the market.

imageimage
image